CHAN MITCHELL (Chief Financial Officer) received a stock award from REGENXBIO INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/8/2026ACC: 0001789335-26-000002
Officer· Chief Financial Officer
Since Sep 2024
+113.40K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
113.40K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+73.75K
Price / share
—
Trade value
—
% of position
136.7%
1/6/2026
53.97K→127.72K
Total
Net shares
+73.75K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/6/2026 | A · Award | +73.75K | — | — | 136.7% | 53.97K | 127.72K |
| Total | +73.75K | $0.00 | ||||||
Derivative Transactions1
Stock Options (Right to buy)
Direct
Converts to
Common Stock
39.65K shares
Shares
+39.65K
Strike price
14.18
Held after
39.65K
Exercisable
—
1/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy) Direct | Common Stock39.65K shares | 1/6/2026 | A · Award | +39.65K | 14.18 | — | 39.65K |